An OHE report analyses the rise in NICE’s optimised decisions from 2025 to 2024 and how they affect patient access, HTA ...

Rosenblatt analyst Catharine Trebnick maintained NICE Ltd (NASDAQ:NICE) with a Buy rating and lowered the price forecast from ...

Sir Jim Ratcliffe is ready to sell Nice, with Saudi Arabia reportedly lurking, after admitting that he doesn't "enjoy" ...